Table 1.
Clinicopathologic characteristics of 149 patients with hepatocellular carcinoma according to treatment modality
Variable | Hepatectomy | Percutaneous ablation |
Age (yr) | ||
≤ 65 | 56 | 33 |
> 65 | 29 | 31 |
Gender | ||
Male | 61 | 43 |
Female | 24 | 21 |
HBsAg | ||
Negative | 61 | 54 |
Positive | 24 | 10 |
HCVAb | ||
Negative | 38 | 11 |
Positive | 47 | 53b |
Cirrhosis | ||
Absent | 38 | 13 |
Present | 47 | 51b |
Child-Pugh classification | ||
A | 74 | 30 |
B plus C | 11 | 34b |
ICG R15 (%) | ||
≤ 10 | 52 | 10 |
> 10 | 33 | 54b |
AST(IU/L) | ||
≤ 50 | 48 | 17 |
> 50 | 37 | 47b |
ALT(IU/L) | ||
≤ 50 | 50 | 23 |
> 50 | 35 | 41b |
AFP (ng/mL) | ||
≤ 20 | 39 | 27 |
> 20 | 46 | 37 |
No. of hepatic tumors | ||
Solitary | 67 | 41 |
Multiple | 18 | 23 |
Tumor size (cm) | ||
≤ 2 | 23 | 43 |
> 2 | 62 | 21b |
ICG R15: indocyanine green retention rate at 15 min.
P < 0.01 between groups.